microRNA biosensors: Opportunities and challenges among conventional and commercially available techniques
dc.contributor.author | Kilic, Tugba | |
dc.contributor.author | Erdem, Arzum | |
dc.contributor.author | Ozsoz, Mehmet | |
dc.contributor.author | Carrara, Sandro | |
dc.date.accessioned | 2019-10-27T10:43:23Z | |
dc.date.available | 2019-10-27T10:43:23Z | |
dc.date.issued | 2018 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | As being the most extensively studied, non-coding, evolutionary conserved, post-transcriptional gene regulators of genome, microRNAs (miRNAs) have taken great attention among various disciplines due to their important roles in biological processes and link with cancer. Due to their diagnostic value, there have been many conventional methods used in detection of miRNAs including northern blotting, quantitative real time PCR (qRT-PCR) and microarray technology besides novel techniques based on various nanotechnology approaches and molecular biology tools including miRNA biosensors. The aim of this review is to explain the importance of miRNAs in biomedical field with an emphasis on early cancer diagnosis by overviewing both research based and commercially available miRNA detection methods in the last decade considering their strengths and weakness with an emphasis on miRNA biosensors. | en_US |
dc.description.sponsorship | Marie CurieEuropean Union (EU) | en_US |
dc.description.sponsorship | Dr. Kilic acknowledges the Horizon 2020, Marie Sklodowska-Curie actions, EPFL fellows international postdoctoral fellowship program co-funded by Marie Curie. | en_US |
dc.identifier.doi | 10.1016/j.bios.2017.08.007 | en_US |
dc.identifier.endpage | 546 | en_US |
dc.identifier.issn | 0956-5663 | |
dc.identifier.issn | 1873-4235 | |
dc.identifier.pmid | 28823978 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 525 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.bios.2017.08.007 | |
dc.identifier.uri | https://hdl.handle.net/11454/30763 | |
dc.identifier.volume | 99 | en_US |
dc.identifier.wos | WOS:000413284200071 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Advanced Technology | en_US |
dc.relation.ispartof | Biosensors & Bioelectronics | en_US |
dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | miRNA | en_US |
dc.subject | Biosensors | en_US |
dc.subject | Cancer | en_US |
dc.subject | Emerging technologies | en_US |
dc.title | microRNA biosensors: Opportunities and challenges among conventional and commercially available techniques | en_US |
dc.type | Review Article | en_US |